| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| T881682 | 1636180-98-7 | Tarloxotinib bromide, 98% Tarloxotinib bromide, 98% |
C24H24Br2ClN9O3 | |
| T797390 | 733030-01-8 | TAS-102, 10mM in DMSO TAS-102, 10mM in DMSO |
C10H11F3N2O5·C9H11ClN4O2·HCl | |
| T872826 | 733030-01-8 | TAS-102, 99% TAS-102, 99% |
C10H11F3N2O5·C9H11ClN4O2·HCl | |
| T881384 | 174634-08-3 | TAS-103, 98% TAS-103, 98% |
C20H19N3O2 | |
| T881383 | 174634-09-4 | TAS-103 dihydrochloride, ≥99% TAS-103 dihydrochloride, ≥99% |
C20H21Cl2N3O2 | |
| T881555 | 1688673-09-7 | TAS-115 mesylate, ≥99% TAS-115 mesylate, ≥99% |
C28H27FN4O7S2 | |
| T884115 | 1190836-34-0 | TAS-115 , 98% TAS-115 , 98% |
C27H23FN4O4S | |
| T881607 | 1661854-97-2 | TAS6417 , 98% TAS6417 , 98% |
C23H20N6O | |
| R873025 | 1282512-48-4 | Taselisib (GDC 0032), 99% RG7604, 99% |
C24H28N8O2 | |
| R797427 | 1282512-48-4 | Taselisib (GDC 0032), 10mM in DMSO RG7604, 10mM in DMSO |
C24H28N8O2 | |
| T737471 | 600125-11-9 | TASK-1-IN-1, 98% TASK-1-IN-1, 98% |
C22H20N2O2 | |
| T882277 | 145733-36-4 | Tasosartan, ≥99% Tasosartan, ≥99% |
C23H21N7O | |
| T879868 | 275371-94-3 | Taspoglutide, ≥97% Taspoglutide, ≥97% |
C152H232N40O45 | |
| T884311 | 1159916-66-1 | TAT 2-4 , 98% TAT 2-4 , 98% |
C132H240N66O29 | |
| T880012 | 253141-50-3 | TAT 48-57 , 98% TAT 48-57 , 98% |
C55H109N31O12 | |
| T881102 | 1834571-04-8 | Tat-NR2B9c TFA, ≥98% Tat-NR2B9c TFA, ≥98% |
C2HF3O2 | |
| T884568 | 110026-03-4 | Taurodeoxychloic Acid sodium hydrate, ≥98% Taurodeoxychloic Acid sodium hydrate, ≥98% |
C26H47NNaO7S+ | |
| T884218 | 117609-50-4 | Tauroursodeoxycholate dihydrate, 97% Tauroursodeoxycholate dihydrate, 97% |
C26H49NO8S | |
| T879934 | 263251-78-1 | Tavilermide, 98% Tavilermide, 98% |
C24H32N6O11 | |
| T877184 | 82989-25-1 | Tazanolast, ≥99% Tazanolast, ≥99% |
C13H15N5O3 |